Abstract
Objective
While topical androgen administration is widely used in the treatment of lichen sclerosus of the vulva, localization and level of expression of androgen receptor (AR) have not been described previously.
Methods
Thirty-nine paraffin-embedded punch biopsies of patients with lichen sclerosus of the vulva were examined. Androgen receptor, estrogen receptor (ER), and progesterone receptor (PR) expression in lichen sclerosus and in normal vulvar skin were investigated by immunohistochemistry.
Results
Five tissue specimens (12.8%) of lichen sclerosus showed nuclear staining with anti-AR in the parabasal cell layers of the epidermis. Median age of patients with positive nuclear staining for AR versus women without AR expression was 71 (range, 63-78) and 66.5 (range, 38-91) years, respectively. Estrogen receptor expression was present in only one patient. Nuclear staining reaction for PR expression was absent in all cases. Four of the five AR-positive women reported no complaints and therefore received no topical testosterone therapy.
Conclusion
Our results suggest a lack of complaints in AR-positive lichen sclerosus patients. Our findings could justify a larger study comparing symptoms of patients with and without AR expression.
Similar content being viewed by others
References
Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991;78:1046–9.
Joura EA, Zeisler H, Bancher-Todesca D, Sator MO, Schneider B, Gitsch G. Short-term effects of topical testosterone in vulvar lichen sclerosus. Obstet Gynecol 1997;89:297–9.
Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994;46:53–6.
Bracco GL, Carli P, Sonni L, et al. Clinical and histologic effect of topical treatments of vulval lichen sclerosus: a critical evaluation. Reprod Med 1993;38:36–40.
Kehoe S, Luesley D. Pathology and management of vulval pain and pruritus. Curr Opin Obstet Gynecol 1995;7:16–9.
Tremanie RD, Miller RA. Lichen sclerosus et atrophicus. Int J Dermatol 1989;28:10–6.
Cantwell AR. Histologic observations of pleomorphic variably acid-fast bacteria in scleroderma, morphea, and lichen scierosus et atrophicus. Int J Dermatol 1984;23:45–52.
Jeffcoate TN. Chronic vulval dystrophies. Am J Obstet Gynecol 1966;95:61–74.
Kaufman M, Straisfeld C, Pinsky L. Expression of androgen-responsive properties in human skin fibroblast strains of genital and nongenital origin. Somat Cell Mol Genet 1977;3:17–25.
Carli P, Bracco G, Taddei G, et al. Vulvar lichen sclerosus: immunohistologic evaluation before and after therapy. J Reprod Med 1994;39:110–4.
Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO, Boersma WJ. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992;133:467–75.
Liang T, Hoyer S, Yu R, et al. Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 1993; 100: 663–6.
Itami S, Kurata S, Sonoda T, Takayasu S. Interaction between dermal papilla cells and follicular epithelial cells in vitro: effect of androgen. Br J Dermatol 1995;132:527–32.
Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990;30:97–100.
Garau JM, di Paola GR, Charreau EH. Estrogen and progesterone receptor assays on the vulvar epithelium. J Reprod Med 1986;31:987–91.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors thank G. Dudek for technical assistance.
Rights and permissions
About this article
Cite this article
Kohlberger, P.D., Joura, E.A., Bancher, D. et al. Evidence of Androgen Receptor Expression in Lichen Sclerosus: An Immunohistochemical Study. Reprod. Sci. 5, 331–333 (1998). https://doi.org/10.1177/107155769800500610
Published:
Issue Date:
DOI: https://doi.org/10.1177/107155769800500610